Clearmind Medicine Inc. Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement
Clearmind Medicine Inc. (CMND) reported Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement of 39129500.00% for the 3-month period ending 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement · last filed 2026-03-12
- Clearmind Medicine Inc. number of other equity instruments exercised or vested in share-based payment arrangement for the quarter ending 2026-01-31 was 39129500.00%, a 28.59% decline year-over-year.
- Clearmind Medicine Inc. number of other equity instruments exercised or vested in share-based payment arrangement for the quarter ending 2025-01-31 was 54792100.00%.
| Period end | Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 3 month | Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 6 month | Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 9 month | Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 12 month | Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 12 month as first filed |
|---|---|---|---|---|---|
| 2026-01-31 | 39129500.00% 6-K · filed 2026-03-12 | ||||
| 2025-10-31 | 54792100.00% 6-K · filed 2026-03-12 | ||||
| 2025-07-31 | 54792100.00% 6-K · filed 2025-09-11 | ||||
| 2025-04-30 | 54792100.00% 6-K · filed 2025-06-12 | ||||
| 2025-01-31 | 54792100.00% 6-K · filed 2025-03-13 | ||||
| 2024-10-31 | 829358500.00% 20-F · filed 2026-01-20 | ||||
| 2023-10-31 | 78458400.00% 20-F · filed 2025-01-22 | 24375.00% 6-K · filed 2024-03-19 | |||
| 2023-10-30 | 24375.00% 6-K · filed 2024-09-16 |